What is NDC 50090-7656?

50090-7656 is the product NDC for Dabigatran Etexilate, Dabigatran etexilate mesylate 75 mg/1 capsule, coated pellets, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dabigatran Etexilate?

30 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dabigatran Etexilate NDC 50090-7656

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-7656Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-7656Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-7656-0	5009076560050090765600	60 CAPSULE, COATED PELLETS in 1 BOTTLE (50090-7656-0)Marketed from Sep 18, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dabigatran Etexilate
Generic name (nonproprietary): dabigatran etexilate
Active ingredients: Dabigatran etexilate mesylate — 75 mg/1
Dosage form: Capsule, Coated pellets
Route: Oral
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208040
Marketing start: Jun 20, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Thrombin Inhibitors (Mechanism)
Identifiers: Product ID 50090-7656_c9ac120f-f8a2-4be5-9060-4f90a2e1ef10SPL ID c9ac120f-f8a2-4be5-9060-4f90a2e1ef10SPL set ID b31d27e9-5502-43c5-83fa-89608c014b7aRxCUI 1037179UNII SC7NUW5IIT
Pharmacologic class: Direct Thrombin Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090765600 followed by a unit qualifier and the quantity

Package 50090-7656-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 22, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Dabigatran Etexilate Capsules is a direct thrombin inhibitor indicated: To reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation ( 1.1 ) For the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in adult patients who have been treated with a parenteral anticoagulant for 5 to 10 days ( 1.2 ) To reduce the risk of recurrence of DVT and PE in adult patients who have been previously treated ( 1.3 ) For the prophylaxis of DVT and PE in adult patients who have undergone hip replacement surgery ( 1.4 ) 1.1 Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation in Adult Patients Dabigatran Etexilate …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50090-7656

What is NDC 50090-7656?: 50090-7656 is the product NDC for Dabigatran Etexilate, Dabigatran etexilate mesylate 75 mg/1 capsule, coated pellets, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dabigatran Etexilate.
What is the active ingredient?: Dabigatran etexilate mesylate.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dabigatran Etexilate?: 30 other product NDCs are listed under this name. See all Dabigatran Etexilate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dabigatran Etexilate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dabigatran Etexilate	Dabigatran etexilate mesylate 150 mg/1	CapsuleOral	NorthStar RxLLC	72603-239	72603-0239-01
Dabigatran Etexilate	Dabigatran etexilate mesylate 110 mg/1	Capsule, Coated pelletsOral	Ascend Laboratories, LLC	67877-624	67877-0624-3167877-0624-60
Dabigatran Etexilate	Dabigatran etexilate mesylate 75 mg/1	Capsule, Coated pelletsOral	Major Pharmaceuticals	0904-7253	00904-7253-0400904-7253-68
Dabigatran Etexilate	Dabigatran etexilate mesylate 110 mg/1	Capsule, Coated pelletsOral	Major Pharmaceuticals	0904-7254	00904-7254-68
Dabigatran Etexilate	Dabigatran etexilate mesylate 150 mg/1	Capsule, Coated pelletsOral	Major Pharmaceuticals	0904-7255	00904-7255-1000904-7255-68
Dabigatran Etexilate	Dabigatran etexilate mesylate 75 mg/1	CapsuleOral	Aurobindo Pharma Limited	59651-973	59651-0973-6059651-0973-61
Dabigatran Etexilate	Dabigatran etexilate mesylate 110 mg/1	CapsuleOral	Aurobindo Pharma Limited	59651-974	59651-0974-6059651-0974-61
Dabigatran Etexilate	Dabigatran etexilate mesylate 150 mg/1	CapsuleOral	Aurobindo Pharma Limited	59651-975	59651-0975-6059651-0975-61
Dabigatran etexilate	Dabigatran etexilate mesylate 110 mg/1	CapsuleOral	Dr.Reddys Laboratories Inc	43598-453	43598-0453-60
Dabigatran etexilate	Dabigatran etexilate mesylate 150 mg/1	CapsuleOral	Dr.Reddys Laboratories Inc	43598-641	43598-0641-60

All 31 Dabigatran Etexilate NDCs

Other NDCs under ANDA 208040

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208040
Product	Strength	Form · route	Labeler	Product NDC
Dabigatran Etexilate	Dabigatran etexilate mesylate 75 mg/1	Capsule, Coated pelletsOral	Major Pharmaceuticals	0904-7253
Dabigatran Etexilate	Dabigatran etexilate mesylate 110 mg/1	Capsule, Coated pelletsOral	Major Pharmaceuticals	0904-7254
Dabigatran Etexilate	Dabigatran etexilate mesylate 150 mg/1	Capsule, Coated pelletsOral	Major Pharmaceuticals	0904-7255
Dabigatran Etexilate	Dabigatran etexilate mesylate 150 mg/1	Capsule, Coated pelletsOral	A-S Medication Solutions	50090-7657
Dabigatran Etexilate	Dabigatran etexilate mesylate 75 mg/1	Capsule, Coated pelletsOral	Ascend Laboratories, LLC	67877-474
Dabigatran Etexilate	Dabigatran etexilate mesylate 150 mg/1	Capsule, Coated pelletsOral	Ascend Laboratories, LLC	67877-475
Dabigatran Etexilate	Dabigatran etexilate mesylate 110 mg/1	Capsule, Coated pelletsOral	Ascend Laboratories, LLC	67877-624